Form 4: Amneal Pharmaceuticals Director J Kevin Buchi Gifts Shares to Trust
SEC Form 4
Director J Kevin Buchi of Amneal Pharmaceuticals gifted 262,072 shares of Class A Common Stock to a trust on March 10, 2025.
Summary
- On March 10, 2025, J Kevin Buchi, a director at Amneal Pharmaceuticals, gifted 262,072 shares of Class A Common Stock to a trust.
- The reporting person is the trustee of the trust, and the son of the reporting person is the sole beneficiary.
- The transaction involved no consideration.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing regarding a gift of shares, so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This transaction represents a gift and not a market sale.
Stakeholder Impact
- The gift of shares to a trust may have a minor impact on shareholders due to the change in beneficial ownership, but it's unlikely to be significant.
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Date of the share gift transaction to a trust |
| 03/12/2025 | Date of signature by Attorney-in-Fact |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.